The experimental results showed that Smo silencing significantly inhibited the proliferation of NKTCL cells, markedly increased the apoptosis rate, and affected the expression of Gli1 and PD-L1 (Fig. 10). The gene discussed is CD274; the disease is extranodal nasal NK/T cell lymphoma.